A Double-blind, Placebo-controlled, Randomized Study Evaluating the Effect of Paliperidone ER Compared With Placebo on Sleep Architecture in Subjects With Schizophrenia.

Trial Profile

A Double-blind, Placebo-controlled, Randomized Study Evaluating the Effect of Paliperidone ER Compared With Placebo on Sleep Architecture in Subjects With Schizophrenia.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 May 2010

At a glance

  • Drugs Paliperidone (Primary)
  • Indications Insomnia; Schizophrenia
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 20 May 2010 Actual patient number added as 5 as reported by ClinicalTrials.gov.
    • 05 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top